Arcutis Biotherapeutics (ARQT) Change in Acquisitions & Divestments (2019 - 2026)

Arcutis Biotherapeutics' Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at $50.8 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 25.77% year-over-year to $50.8 million; the TTM figure through Mar 2026 stood at $209.8 million (down 25.08% YoY), while the FY2025 annual figure was $227.4 million, down 21.25% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $50.8 million, down from $55.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $147.5 million in Q1 2023, with the low at $43.3 million in Q3 2025.
• The 5-year median for Change in Acquisitions & Divestments is $68.0 million (2023), against an average of $77.9 million.
• The sharpest annual moves came in 2022 and 2024: Change in Acquisitions & Divestments surged 182.74% in 2022, then slumped 52.86% in 2024.
• Arcutis Biotherapeutics' Change in Acquisitions & Divestments stood at $80.4 million in 2022, then sank by 30.36% to $56.0 million in 2023, then increased by 2.28% to $57.3 million in 2024, then fell by 3.97% to $55.0 million in 2025, then fell by 7.6% to $50.8 million in 2026.
• Business Quant data shows ARQT's Change in Acquisitions & Divestments at $50.8 million in Q1 2026, $55.0 million in Q4 2025, and $43.3 million in Q3 2025.